Trials / Sponsors / Usona Institute
Usona Institute
Academic / Other · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Psilocybin for Major Depressive Disorder (MDD) Depressive Disorder, Major | Phase 3 | 2024-03-13 |
| Completed | Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers Pharmacokinetics, Safety, Tolerability | Phase 1 | 2022-12-27 |
| Completed | An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmaco QTc Interval, Pharmacokinetics | Phase 1 | 2022-06-22 |
| Terminated | PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder Major Depressive Disorder | — | 2020-06-30 |
| Completed | A Study of Psilocybin for Major Depressive Disorder (MDD) Depressive Disorder, Major | Phase 2 | 2019-10-15 |